Methotrexate Nephrotoxicity: What You Need to Know

When dealing with methotrexate nephrotoxicity, kidney damage that can arise from the drug methotrexate. Also known as MTX‑induced renal injury, it is a serious side effect that clinicians and patients must watch for.

The culprit, methotrexate, a folate‑blocking medication used for cancer and autoimmune diseases, can accumulate in the renal tubules when doses are high or the kidneys are already stressed. A single overdose or chronic high‑dose therapy often triggers a rise in serum creatinine within days. Knowing the dose‑response relationship helps decide when to lower the dose or pause treatment.

Nephrotoxicity, toxicity that impairs kidney function isn’t limited to methotrexate; many drugs share this risk. For methotrexate, key risk factors include pre‑existing kidney disease, dehydration, and concurrent use of NSAIDs that reduce renal blood flow. Even common over‑the‑counter pain relievers can push a borderline kidney into trouble.

Prevention centers on folate supplementation, adding folic acid or leucovorin to counteract methotrexate's folate blockade. Daily folic acid (1‑5 mg) or a weekly leucovorin rescue dose reduces the incidence of both hepatic and renal toxicity. Patients who skip their supplement often report higher rates of nausea, mouth sores, and rising creatinine levels.

Monitoring should start before the first dose and continue weekly for high‑dose regimens. Track serum creatinine, blood urea nitrogen, and calculate creatinine clearance to gauge kidney filtration. Urinalysis can reveal crystal formation, a tell‑tale sign that methotrexate is precipitating in the tubules.

If toxicity emerges, immediate actions include aggressive hydration to flush the drug, urine alkalinization with sodium bicarbonate, and temporary discontinuation of methotrexate. In severe cases, dialysis may be required to clear accumulated drug. Early intervention often leads to reversible injury; delayed response can cause permanent loss of function.

Drug interactions matter too. Proton‑pump inhibitors, sulfonamides, and certain antibiotics can raise methotrexate levels by inhibiting renal excretion. Always review a patient’s medication list before starting or adjusting methotrexate therapy.

Outcomes vary. Many patients recover fully once the offending dose is stopped and supportive care is given. However, some develop chronic kidney disease, especially if multiple risk factors overlapped. Long‑term follow‑up is essential to detect late‑onset decline.

Below you’ll find a collection of articles that dive deeper into each of these points—risk assessment, dosing tricks, supplement strategies, and step‑by‑step management plans. Use them as a practical toolbox to keep methotrexate working for you without hurting your kidneys.

Methotrexate and Kidney Health: How to Keep Your Kidneys Safe
Aug, 10 2025

Methotrexate and Kidney Health: How to Keep Your Kidneys Safe

Learn how methotrexate can affect kidney health, how to monitor function, and practical steps to protect your kidneys while staying on treatment.